To receive all the financial information of AMPLITUDE in real time, send a request by email to [email protected]
Amplitude Surgical (ISIN: FR0012789667, Mnémo: AMPLI, PEA-PME eligible), French leader in the market for surgical technologies intended for orthopedics for the lower limbs, announces the launch of a strategic review of its Novastep activity specializing in the extremity surgery (feet and ankles).
The Board of Directors, which met on June 28, 2022, issued the recommendation to launch a strategic review of the activity specializing in extremity surgery (feet and ankles), carried out by the Novastep subsidiaries in France and the United States. United, with the objective of maximizing value creation and pursuing the development of the Amplitude Surgical Group. The review to be carried out by the Group could possibly lead to the sale of this activity. In the coming weeks, the Group will appoint the financial advisors to support it in this review.